Ajanta Pharma quarterly results and financials

Ajanta Pharma (AJANTPHARM)₹3,344+0.17%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Sep 2026 quarter (consolidated), Ajanta Pharma reported sales of ₹1,791 Cr, up 32.4% from Sep 2025, and net profit of ₹388 Cr, up 49.3% year on year. For the year to Mar 2026, sales were ₹5,442 Cr and net profit ₹1,055 Cr.

Sales (Sep 2026): ₹1,791 Cr
Net profit (Sep 2026): ₹388 Cr
Sales (FY Mar 2026): ₹5,442 Cr
Net profit (FY Mar 2026): ₹1,055 Cr
EPS (Sep 2026): ₹31.03
Borrowings (Mar 2026): ₹260 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Ajanta Pharma quarterly results

₹ crore unless stated; each column is a quarter.

Ajanta Pharma Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	1,104	1,052	1,144	1,185	1,144	1,168	1,302	1,352	1,372	1,419	1,624	1,791
Expenses	789	773	813	872	823	870	948	1,023	990	1,086	1,199	1,243
Operating Profit	313	277	329	310	320	296	350	327	381	332	423	547
OPM %	28.1%	26.1%	29.1%	26.1%	28.1%	25.1%	27.1%	24.0%	28.0%	23.1%	26.1%	31.1%
Other Income	13.99	35.99	25.97	18.99	29.99	17.97	25.96	58.91	24.99	60.94	70.90	36.97
Interest	1.99	1.99	0.99	5.98	7.97	5.98	4.98	2.99	4.99	1.99	2.99	1.99
Depreciation	34.12	34.11	34.09	34.09	36.08	40.12	41.10	43.15	44.13	45.15	44.13	48.12
Profit before tax	290	277	321	289	306	268	330	340	358	346	446	533
Tax %	28.0%	27.0%	24.0%	25.0%	24.0%	16.0%	23.0%	24.0%	24.0%	23.0%	25.0%	27.0%
Net Profit	210	203	246	216	233	225	255	260	274	267	333	388
EPS (Rs)	16.38	15.81	19.69	17.34	18.62	18.02	20.45	20.81	21.89	21.34	26.73	31.03

Ajanta Pharma profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Ajanta Pharma Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,745	1,981	2,121	2,052	2,583	2,887	3,334	3,734	4,202	4,640	5,442	6,205
Expenses	1,151	1,289	1,463	1,485	1,898	1,883	2,400	2,927	3,026	3,367	3,944	4,517
Operating Profit	593	690	657	565	681	999	931	807	1,168	1,265	1,497	1,683
OPM %	34.1%	35.0%	31.1%	28.1%	26.1%	35.0%	28.1%	22.0%	28.1%	27.1%	28.1%	27.1%
Other Income	13.98	19.97	23.96	20.99	87.88	23.99	112	73.98	84.97	84.87	66.94	194
Interest	4.98	0.99	0.00	0.99	11.95	7.98	9.96	5.98	6.98	20.94	15.94	11.96
Depreciation	44.15	61.13	60.19	72.16	96.32	116	125	131	135	144	174	182
Profit before tax	557	645	620	513	662	896	906	743	1,109	1,185	1,372	1,682
Tax %	26.0%	22.0%	25.0%	25.0%	30.0%	27.0%	22.0%	21.0%	27.0%	23.0%	23.0%	—
Exceptional items	−1.01	−3.01	0.00	0.00	−3.01	3.01	−1.01	−6.03	8.03	4.02	−73.28	—
Net Profit	416	506	468	387	467	653	712	587	814	920	1,055	1,262
EPS (Rs)	31.48	38.38	35.47	29.53	35.69	50.37	55.61	45.90	63.69	73.66	84.50	100.99
Dividend payout %	17.0%	22.9%	0.0%	20.0%	24.0%	13.0%	11.0%	15.0%	78.9%	37.9%	33.0%	—

Ajanta Pharma balance sheet

₹ crore, at each year end.

Ajanta Pharma Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	17.93	17.93	17.94	17.93	17.94	17.94	16.93	16.94	24.91	24.91	24.92	24.90
Reserves	824	1,175	1,551	2,022	2,229	2,583	2,978	3,247	3,368	3,545	3,767	4,508
Borrowings	71.88	80.89	1.01	2.00	35.93	74.82	30.92	24.94	35.94	34.93	46.90	260
Other Liabilities	232	206	253	381	381	616	699	708	1,153	923	1,062	1,244
Total Liabilities	1,146	1,480	1,823	2,423	2,663	3,292	3,725	3,997	4,581	4,528	4,901	6,036
Fixed Assets	287	450	588	1,050	1,175	1,469	1,537	1,507	1,492	1,476	1,756	1,861
CWIP	171	241	340	61.22	263	133	108	153	210	257	177	259
Investments	59.99	85.93	182	190	77.93	78.99	176	147	535	349	463	587
Other Assets	629	704	714	1,122	1,148	1,611	1,904	2,189	2,344	2,447	2,505	3,329
Inventories	158	204	210	350	435	494	763	789	814	825	900	936
Trade receivables	259	373	324	461	460	777	739	1,023	1,059	1,251	1,186	1,859
Cash & equivalents	136	42.82	69.71	92.59	101	204	209	211	330	131	175	105
Total Assets	1,146	1,480	1,823	2,423	2,663	3,292	3,725	3,997	4,581	4,528	4,901	6,036

Ajanta Pharma cash flow

₹ crore, for each year.

Ajanta Pharma Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	279	326	609	281	375	457	576	562	793	786	1,156	529
Cash from investing activity	−157	−208	−381	−255	−222	−223	−281	−73.67	−558	64.80	−375	−427
Cash from financing activity	−105	−117	−203	0.00	−148	−130	−319	−462	−108	−1,055	−736	−169
Net cash flow	15.97	0.00	23.96	24.93	3.99	104	−23.96	27.94	124	−201	46.94	−67.90
Capex	104	299	300	263	343	239	172	149	174	152	319	366
Free cash flow	176	28.98	313	18.98	32.01	228	417	431	617	645	840	169
CFO / OP %	84.1%	82.0%	110.0%	64.0%	87.1%	89.0%	81.1%	86.0%	117.1%	94.1%	117.1%	59.1%

Ajanta Pharma ratios

Working-capital days and returns, by year.

Ajanta Pharma Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	65	79	60	80	83	110	94	112	104	109	94	125
Inventory days	159	180	186	315	415	276	434	347	283	283	308	289
Days payable	109	128	157	224	214	202	212	143	147	159	155	168
Cash conversion cycle	114	130	88	170	282	184	315	315	240	233	246	246
Working capital days	55	77	64	102	112	107	125	139	82	118	96	110
ROCE %	57.0%	52.0%	46.0%	34.0%	24.0%	27.0%	32.0%	29.0%	23.0%	32.0%	32.0%	35.0%

Ajanta Pharma: frequently asked questions

What are the latest quarterly results of Ajanta Pharma?

For the Sep 2026 quarter, Ajanta Pharma reported sales of ₹1,791 Cr, up 32.4% year on year and net profit of ₹388 Cr, up 49.3% year on year. The operating margin was 31.1%.

What is the annual revenue of Ajanta Pharma?

Ajanta Pharma's sales for the year to Mar 2026 were ₹5,442 Cr; over the last twelve months they were ₹6,205 Cr.

What is the net profit of Ajanta Pharma?

Net profit for the year to Mar 2026 was ₹1,055 Cr, and ₹1,262 Cr over the last twelve months. Earnings per share over the same trailing period were ₹100.99.

How much debt does Ajanta Pharma have?

Ajanta Pharma reported borrowings of ₹260 Cr at Mar 2026, against cash and equivalents of ₹105 Cr.

What is the free cash flow of Ajanta Pharma?

Cash from operations was ₹529 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹169 Cr.

Loading…